(Q45424654)

14 December 2017

title

Interferon-alpha suppresses liver cell proliferation in patients with chronic hepatitis C virus infection (English)

1 reference

14 December 2017

1 reference

1 reference

M F Donato

1

1 reference

14 December 2017

C Degott

2

1 reference

14 December 2017

E Arosio

3

1 reference

14 December 2017

M Martinot

4

1 reference

14 December 2017

V Monti

5

1 reference

14 December 2017

A Morabito

6

1 reference

14 December 2017

P Marcellin

7

1 reference

14 December 2017

M Colombo

8

1 reference

14 December 2017

publication date

1 September 2005

1 reference

Journal of Viral Hepatitis

14 December 2017

published in

1 reference

14 December 2017

volume

12

1 reference

14 December 2017

issue

5

1 reference

14 December 2017

page(s)

499-506

1 reference

High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity.

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

Liver regeneration: methods for monitoring and their applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

Hepatocellular proliferation and development of hepatocellular carcinoma: a case-control study in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

Long-term high-dose interferon-α therapy delays Hepadnavirus-related hepatocarcinogenesis in X/myc transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

Proliferating cell nuclear antigen assessed by a computer-assisted image analysis system in patients with chronic viral hepatitis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00625.X

10.1111/J.1365-2893.2005.00625.X

21 January 2018

Identifiers

DOI

1 reference

release_d3qb7nxfrrgmrmay2ketmdk7au

14 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d3qb7nxfrrgmrmay2ketmdk7au

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference